SpectraGenetics
SpectraGenetics
Categories
Biotech Pharmaceutical
About
SpectraGenetics is a GPCR Company with proprietary technology for the direct measurement of GPCR internalization, trafficking and recylcling back to the cell membrane. This technology does not rely on secondary messengers or require imaging. It is based on Fluorogen Activating Peptide (FAP) technology originally developed at Carnegie Mellon University. The company has tagged more than 150 GPCRs and has validated more than 30 cell lines.
Get Updates
from LSPA
Stay up-to-date on the latest news and events from Life Sciences PA, insights from the life sciences industry, and so much more!
Life Sciences Pennsylvania was founded in 1989 by a biotech scientist at Penn State University. Today it has grown to represent the entire life sciences industry – medical device companies, pharmaceutical companies, investment organizations, research institutions, and myriad service industries that support the life sciences in Pennsylvania.